C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/240.3, 260/2
C07D 243/26 (2006.01) C07D 243/24 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07H 5/06 (2006.01) C07H 13/12 (2006.01)
Patent
CA 1202023
Abstract Novel pharmaceutically active substances which inhibit the intestinal resorption of cholesterol and which accordingly can be used in the control or prevention of atherosclerosis are described. These active substances, namely benzodiazepines of the general formula Image I wherein R1 signifies (C1-C4)-alkyl, R2 signifies hydrogen or methyl, R3 and R4 each signify halogen and R5 signifies (C3-C9)-alkylamino substituted by at least two hydroxy groups, (C3-C6)- -cycloalkylamino substituted by at least one hydroxy group, glucosamino, galactos- amino, mannosamino, monohydroxy-1-azeti- dinyl, mono- or dihydroxy-1-pyrrolidinyl
416049
Cassal Jean-Marie
Fischli Albert E.
Szente Andre
Gowling Lafleur Henderson Llp
Hoffmann-La Roche Limited
LandOfFree
Benzodiazepines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodiazepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodiazepines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1289231